article thumbnail

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

OrthoSpineNews

No serious adverse events (SAEs) were reported, and there was no dose (40X10 6 cells) limiting toxicity at 26-104 weeks. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.

article thumbnail

Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device

OrthoSpineNews

This event marks the beginning of SST’s U.S.-based based trial to evaluate its PerQdisc system for patients suffering from degenerative disc disease (DDD). patient in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BioRestorative Announces Share Repurchase Program

OrthoSpineNews

We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have also obtained U.S.

article thumbnail

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

OrthoSpineNews

Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD).

article thumbnail

Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine

OrthoSpineNews

million of the aggregate purchase price was paid to Xtant as a non-refundable cash deposit, except in the event Companion Spine terminates the Coflex/CoFix agreement due to certain breaches by Xtant under the agreement. million cash deposits may be paid to Xtant by Companion Spine in the event it requires extra time to obtain financing.

article thumbnail

Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval

OrthoSpineNews

The first post-approval procedure on an adult patient with degenerative disc disease (DDD) was performed by neurosurgeon Sharad Rajpal, M.D., I am proud to have performed the first post-approval procedure using PearlMatrix Bone Graft, a novel approach to treating degenerative disc disease,” said Sharad Rajpal M.D.,

article thumbnail

The 18 Most Popular Chiropractic Tools and Equipment

ChiroTouch

Lightweight and easily transportable, portable tables are ideal for chiropractors who offer mobile services or need a flexible option for outreach events and home visits. These are standard tables used in many practices, providing a stable and reliable surface for various manual adjustments and treatments. Portable tables. Elevation tables.